Halozyme Therapeutics Inc. buy Morgan Stanley
Start price
10.08.23
/
50%
€40.11
Target price
10.08.24
€55.35
Performance (%)
26.55%
End price
11.08.24
€50.76
Summary
This prediction ended on 11.08.24 with a price of €50.76. The prediction had a final performance of 26.55%. Morgan_Stanley has a follow-up prediction for Halozyme Therapeutics Inc. where he still thinks Halozyme Therapeutics Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Halozyme Therapeutics Inc. | 8.481% | 8.481% | 55.399% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by Morgan_Stanley for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at Morgan Stanley from $60.00 to $61.00. They now have an "overweight" rating on the stock.
Ratings data for HALO provided by MarketBeat
In the thread Trading Halozyme Therapeutics Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€34.03
26.12.23
26.12.23
€53.50
26.12.24
26.12.24
61.80%
16:24
16:24
Stopped prediction by Morgan_Stanley for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.79
07.08.24
07.08.24
€58.59
07.08.25
07.08.25
10.58%
16:24
16:24
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€42.50
06.03.23
06.03.23
€60.06
06.03.24
06.03.24
-10.61%
07.03.24
07.03.24